Company / Gross Margin
NEPHROS INC Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
61.9%
FY2025
5-year range
47.4% / 61.9%
FY2021-FY2025
Trend
+4.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 47.4% to 61.9% over the past 2 years.
Based on SEC 10-K filings.
61.9% in FY2025 with a 5-year CAGR of +4.5%.
Improved from 47.4% to 61.9% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +14.4pp
- 5-Year Change
- +4.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin increased 4.8% year-over-year.
- Lowest gross margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 61.9% | +4.8% |
| FY2024 | 59.0% | +24.5% |
| FY2023 | 47.4% | +0.0% |
| FY2022 | 47.4% | -14.0% |
| FY2021 | 55.1% | -3.9% |
| FY2020 | 57.4% | -2.5% |
| FY2019 | 58.9% | +4.5% |
| FY2018 | 56.3% | +1.0% |
| FY2017 | 55.8% | +0.0% |
| FY2016 | 55.8% | +2.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026